Fiscal Year End Company Status Exempt Flag June 30 Trading N Board of Directors Name Position Eugene Beukman  Director of the Board Peter Chen  Secretary of the Board Terrance Owen  Director of the Board   President Tom Kennedy  Director of the Board Incorporation Locations Inc. Date Expiry Date Country Region Description 30/May/2000    Canada  British Columbia    Exchange Filing Office Location Vancouver Regional Service Office		Business Type(s) Primary/Secondary Business Type Details Primary  Developing, manufacturing and selling infection control products  (not available)  Securities Symbol Security Name Market Status APH ALDA Pharmaceuticals Corp. TSX Venture TRADING Name History From To ALDA Pharmaceuticals Corp. 27/Nov/2003 Present Company Facts Reconciliation Subject Date Returned Spring 2012 CFR 22/Aug/2012 Associations Auditing Firm:  Meyers Norris Penny LLP Sponsor:  Wolverton Securities Ltd. Subsidiary:  Sirona Therapeutics Corp. Transfer Agent:  Computershare Trust Company of Canada
Latest Information Type Date Title News Releases  16/Nov/2012  NEWS RELEASE - NEW DIRECTORS JOIN THE BOARD OF ALDA[MARKET NEWS]     NEWS RELEASE - ACQUIRES RIGHTS TO FERROHEME A NOVEL PROPRIETA[MARKET NEWS]     NEWS RELEASE - RECEIVES CONDITIONAL APPROVAL FOR DEBT SETTLEMEN[MARKET NEWS] Bulletins  13/May/2013  PP-N-B Meetings and Public Filings    Information on financial statements, public filings and corporate meetings for all Canadian public companies can be found at www.sedar.com
Property Locations (not available)

* Historical Data